Exercise Training in Chronic Obstructive Pulmonary Disease (COPD)
NCT ID: NCT01218282
Last Updated: 2010-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2008-01-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is designed to evaluate different methods of exercise training at home, to help understanding and maintaining the walking intensity in COPD patients. Outcome: exercise performance, daily physical activity and respiratory function.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home Exercise Training Group A1
Patients assigned to this arm maintain the prescribed walking speed during the training with a metronome
Home exercise training
20-30 min/day for at least 4 days/week
Home Exercise Training Group A2
Patients assigned to this arm cover a fixed distance in a given period of time.
Home exercise training
20-30 min/day for at least 4 days/week
Control
NO Exercise Training
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home exercise training
20-30 min/day for at least 4 days/week
NO Exercise Training
No intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Università degli Studi di Ferrara
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Ferrara
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annalisa Cogo, MD
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi di Ferrara
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pulmonary respiratory unit- University Hospital
Ferrara, Ferrara, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ExTCOPD01
Identifier Type: -
Identifier Source: org_study_id